The instruction for medical use
of Advans Torgovoye Terafleks® medicine a name
of Terafleks® Advans
the International unlicensed name
Is not present
the Dosage form
of the Structure One Capsule Capsule contains
active agents: a glycosamine sulfate of 250 mg, chondroitin sulfate (in the form of sodium sulfate chondroitin) 200 mg, an ibuprofen (in the form of mix of an ibuprofen of 66%) 100 mg,
excipients: the cellulose microcrystalline silicated, starch corn prezhelatinizirovanny, stearic acid, sodium of starch glikolit, krospovidon, magnesium stearate, polyvinylpirrolidone, silicon dioxide.
Structure of the capsule: gelatin, titan dioxide (E 171), varnish blue FD&C No. 1 (E133).
The description
Solid gelatin capsules of size No. of 0 C a blue cover and the white body with the inscription THERAFLEX ADVANCE. Contents of capsules: powder, white or white with insignificant shades, with a slight smell.
Pharmacotherapeutic group
Other drugs for treatment of diseases of the musculoskeletal system.
The ATX M09AX code
the Pharmacological
Chondroitin properties sulfate participates in construction and restoration of cartilaginous tissue, protects it from destruction and improves mobility of joints. Has anti-inflammatory effect, promotes decrease in intensity of a pain syndrome.
A glycosamine sulfate activates synthesis of the proteoglycans, hyaluronic, chondroitinsulphuric acids and other substances which are a part of articulate covers, intra articulate liquid and cartilaginous tissue.
The ibuprofen renders fast soothing, anti-inflammatory, febrifugal effect.
The drug Teraflex Advans reduces constraint and promotes increase in volume of the movement in joints.
Indications
– in an aggravation phase in primary and secondary osteoarthrosis
– in other degenerative dystrophic diseases of joints of extremities and intervertebral disks
– in injuries of joints
the Adult to apply the Route of administration and doses to simplification of a pain syndrome on 2 capsules 2-3 times a day after a meal. Capsules accept inside, washing down with a small amount of water. Duration of reception should not exceed 20 days. The maximum daily dose – 12 capsules. After elimination of a pain syndrome it is desirable to continue the Teraflex drug treatment of the capsule.
Side effects
Are possible:
– nausea, an abdominal pain, a meteorism, diarrhea or a constipation
– a headache, sleep disorders, dizziness
– allergic reactions
After drug withdrawal all manifestations disappear.
Contraindications
– the increased individual sensitivity to any of drug ingredients
– GIT erosive cankers in an aggravation phase
– diseases of an optic nerve
– hemopoiesis disturbance
– the significant disturbances of functions of a liver or kidneys
– chronic heart failure
– aspirinovy asthma
– phenylketonuria
– children's age up to 18 years
– pregnancy and the period of a lactation
Medicinal interactions
Drug improves digestion of tetracyclines and reduces digestion of penicillin and chloramphenicol. Reduces effect of antihypertensive drugs (APF inhibitors, beta blockers, diuretics (furosemide, a hydrochlorothiazide), strengthens action of antiagregant, fibrinolitik and also coumarinic anticoagulants (for example, warfarin), at a concomitant use with these drugs indicators of a koagulogramma (MNO) can change and raise risk of bleedings.
Simultaneous use with non-steroidal anti-inflammatory drugs and glucocorticosteroids (NPVS, GKS) increases risk of development of side effect from digestive tract.
Special instructions
not to exceed the recommended dose and duration of reception.
Features of influence on ability to run transport or potentsialnoopasny mechanisms
the Overdose does not influence
the Overdose for drug is not described. In case of overdose the gastric lavage, intake of activated carbon, hospitalization in toxicological department is recommended.
The form of release and packing
On 60 capsules place in bottles from polyethylene of high density with the screw-on cover. The neck of a bottle is sealed up a protective membrane from the combined material – aluminum foil / the paper laminated by polyethylene. The cover of a bottle is sealed up a protective film. On a bottle paste the label from self-adhesive paper.
The bottle together with the instruction for medical use in the state and Russian languages is placed in a cardboard box.
To Store storage conditions at a temperature not above 25 °C.
To store out of children's reach!
2 years
not to use a period of storage after the expiration date specified on packing.
Prescription status
Without prescription
the Name and the country
of the Contract Pharmakal Corporation manufacturing organization, 135 Adams Avenue, Hopog, New York 11788, the USA
the Name and the country of the owner of the registration certificate
of Bayer Konsyyumer Ker AG, Switzerland
the Name and the country
of the organization packer Contract Pharmakal Corporation, USA Adres of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of a product (goods):
Bayer of KAZ LLP
050057, Almaty, Republic of Kazakhstan Timiryazev St., 42, business center Expo-City, peahens. 15
Ph.: +7 727 258 80 40
Fax: +7 727 244 70 01
e-mail: kz.claims@bayer.com
of Advans Torgovoye Terafleks® medicine a name
of Terafleks® Advans
the International unlicensed name
Is not present
the Dosage form
of the Structure One Capsule Capsule contains
active agents: a glycosamine sulfate of 250 mg, chondroitin sulfate (in the form of sodium sulfate chondroitin) 200 mg, an ibuprofen (in the form of mix of an ibuprofen of 66%) 100 mg,
excipients: the cellulose microcrystalline silicated, starch corn prezhelatinizirovanny, stearic acid, sodium of starch glikolit, krospovidon, magnesium stearate, polyvinylpirrolidone, silicon dioxide.
Structure of the capsule: gelatin, titan dioxide (E 171), varnish blue FD&C No. 1 (E133).
The description
Solid gelatin capsules of size No. of 0 C a blue cover and the white body with the inscription THERAFLEX ADVANCE. Contents of capsules: powder, white or white with insignificant shades, with a slight smell.
Pharmacotherapeutic group
Other drugs for treatment of diseases of the musculoskeletal system.
The ATX M09AX code
the Pharmacological
Chondroitin properties sulfate participates in construction and restoration of cartilaginous tissue, protects it from destruction and improves mobility of joints. Has anti-inflammatory effect, promotes decrease in intensity of a pain syndrome.
A glycosamine sulfate activates synthesis of the proteoglycans, hyaluronic, chondroitinsulphuric acids and other substances which are a part of articulate covers, intra articulate liquid and cartilaginous tissue.
The ibuprofen renders fast soothing, anti-inflammatory, febrifugal effect.
The drug Teraflex Advans reduces constraint and promotes increase in volume of the movement in joints.
Indications
– in an aggravation phase in primary and secondary osteoarthrosis
– in other degenerative dystrophic diseases of joints of extremities and intervertebral disks
– in injuries of joints
the Adult to apply the Route of administration and doses to simplification of a pain syndrome on 2 capsules 2-3 times a day after a meal. Capsules accept inside, washing down with a small amount of water. Duration of reception should not exceed 20 days. The maximum daily dose – 12 capsules. After elimination of a pain syndrome it is desirable to continue the Teraflex drug treatment of the capsule.
Side effects
Are possible:
– nausea, an abdominal pain, a meteorism, diarrhea or a constipation
– a headache, sleep disorders, dizziness
– allergic reactions
After drug withdrawal all manifestations disappear.
Contraindications
– the increased individual sensitivity to any of drug ingredients
– GIT erosive cankers in an aggravation phase
– diseases of an optic nerve
– hemopoiesis disturbance
– the significant disturbances of functions of a liver or kidneys
– chronic heart failure
– aspirinovy asthma
– phenylketonuria
– children's age up to 18 years
– pregnancy and the period of a lactation
Medicinal interactions
Drug improves digestion of tetracyclines and reduces digestion of penicillin and chloramphenicol. Reduces effect of antihypertensive drugs (APF inhibitors, beta blockers, diuretics (furosemide, a hydrochlorothiazide), strengthens action of antiagregant, fibrinolitik and also coumarinic anticoagulants (for example, warfarin), at a concomitant use with these drugs indicators of a koagulogramma (MNO) can change and raise risk of bleedings.
Simultaneous use with non-steroidal anti-inflammatory drugs and glucocorticosteroids (NPVS, GKS) increases risk of development of side effect from digestive tract.
Special instructions
not to exceed the recommended dose and duration of reception.
Features of influence on ability to run transport or potentsialnoopasny mechanisms
the Overdose does not influence
the Overdose for drug is not described. In case of overdose the gastric lavage, intake of activated carbon, hospitalization in toxicological department is recommended.
The form of release and packing
On 60 capsules place in bottles from polyethylene of high density with the screw-on cover. The neck of a bottle is sealed up a protective membrane from the combined material – aluminum foil / the paper laminated by polyethylene. The cover of a bottle is sealed up a protective film. On a bottle paste the label from self-adhesive paper.
The bottle together with the instruction for medical use in the state and Russian languages is placed in a cardboard box.
To Store storage conditions at a temperature not above 25 °C.
To store out of children's reach!
2 years
not to use a period of storage after the expiration date specified on packing.
Prescription status
Without prescription
the Name and the country
of the Contract Pharmakal Corporation manufacturing organization, 135 Adams Avenue, Hopog, New York 11788, the USA
the Name and the country of the owner of the registration certificate
of Bayer Konsyyumer Ker AG, Switzerland
the Name and the country
of the organization packer Contract Pharmakal Corporation, USA Adres of the organization accepting in the territory of the Republic of Kazakhstan claims from consumers on quality of a product (goods):
Bayer of KAZ LLP
050057, Almaty, Republic of Kazakhstan Timiryazev St., 42, business center Expo-City, peahens. 15
Ph.: +7 727 258 80 40
Fax: +7 727 244 70 01
e-mail: kz.claims@bayer.com
Related Products
Laboratorios Menarini S.A. (Spain)
Nimesil® granules for oral suspension 100 mg/2 g, 30 sachets
$32.70
